BIO Investment & Growth Summit is set to take place March 2–3, 2026, in Miami Beach, bringing together biotech executives, investors, and innovators at a critical moment for the life sciences funding landscape.
Organized by the Biotechnology Innovation Organization, the BIO Investment & Growth (BIG) Summit is designed to help companies navigate today’s challenging capital environment while positioning themselves for sustainable, long-term growth.
A timely meeting for biotech leaders and investors
With just weeks remaining until the event, momentum is building as attendees finalize meeting schedules, prioritize strategic sessions, and line up one-on-one conversations. The BIG Summit offers a focused environment where decision-makers meet decision-makers, enabling meaningful discussions around financing, partnerships, and growth strategies.
Participants attending the summit will have the opportunity to:
- Learn how peer organizations are successfully securing capital despite market headwinds
- Connect directly with active life science investors and strategic partners
- Gain insight into how companies are positioning themselves for their next phase of growth
- Participate in high-value networking designed to accelerate business development
Rather than a broad industry conference, the BIG Summit emphasizes targeted connections and actionable outcomes, helping attendees move from conversation to execution.
Registration and hotel deadline
Registration is currently open, and early commitment ensures access to scheduled meetings, curated sessions, and networking opportunities. Attendees are encouraged to register promptly to avoid missing key conversations as agendas quickly fill.
In addition, the hotel booking deadline is Wednesday, February 11, 2026. Discounted rates are available through the official BIG Summit hotel block until that date or until availability is exhausted. Booking early ensures convenient accommodation close to the event venue.
Sponsors and industry support
The BIO Investment & Growth Summit is supported by leading organizations across biotechnology, healthcare, and investment, including Cytovance Biologics, Johnson & Johnson, and Syneos Health as premier sponsors. Additional conference sponsors represent expertise across consulting, insurance, regulatory strategy, and life science media.
Driving the next phase of biotech growth
At a time when access to capital and strategic alignment are more important than ever, the BIO Investment & Growth Summit provides a platform for biotech companies to gain visibility, build investor relationships, and define their growth trajectory.
For organizations seeking funding, partnerships, or strategic guidance, the BIG Summit represents a key opportunity to engage with the people shaping the future of biotechnology.